Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Depreciation and Depletion (2018 - 2025)

Historic Depreciation and Depletion for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $3.8 million.

  • Health Catalyst's Depreciation and Depletion rose 2258.06% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year increase of 1349.21%. This contributed to the annual value of $12.8 million for FY2024, which is 158.73% up from last year.
  • Per Health Catalyst's latest filing, its Depreciation and Depletion stood at $3.8 million for Q3 2025, which was up 2258.06% from $3.6 million recorded in Q2 2025.
  • In the past 5 years, Health Catalyst's Depreciation and Depletion registered a high of $3.8 million during Q3 2025, and its lowest value of $700000.0 during Q1 2021.
  • In the last 5 years, Health Catalyst's Depreciation and Depletion had a median value of $3.1 million in 2023 and averaged $2.8 million.
  • In the last 5 years, Health Catalyst's Depreciation and Depletion surged by 22857.14% in 2022 and then crashed by 312.5% in 2023.
  • Over the past 5 years, Health Catalyst's Depreciation and Depletion (Quarter) stood at $2.0 million in 2021, then skyrocketed by 60.0% to $3.2 million in 2022, then decreased by 3.12% to $3.1 million in 2023, then rose by 6.45% to $3.3 million in 2024, then rose by 15.15% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $3.6 million for Q2 2025, and $3.6 million during Q1 2025.